Micromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regenerationKamps, J. A. A. M. & Krenning, G., 26-Feb-2016, In : World Journal of Cardiology. 8, 2, p. 163-179 17 p.
Research output: Contribution to journal › Article › Academic › peer-review
The loss of cardiomyocytes during injury and disease can result in heart failure and sudden death, while the adult heart has a limited capacity for endogenous regeneration and repair. Current stem cell-based regenerative medicine approaches modestly improve cardiomyocyte survival, but offer neglectable cardiomyogenesis. This has prompted the need for methodological developments that crease de novo cardiomyocytes. Current insights in cardiac development on the processes and regulatory mechanisms in embryonic cardiomyocyte differentiation provide a basis to therapeutically induce these pathways to generate new cardiomyocytes. Here, we discuss the current knowledge on embryonic cardiomyocyte differentiation and the implementation of this knowledge in state-of-the-art protocols to the direct reprogramming of cardiac fibroblasts into de novo cardiomyocytes in vitro and in vivo with an emphasis on microRNA-mediated reprogramming. Additionally, we discuss current advances on state-of-the-art targeted drug delivery systems that can be employed to deliver these microRNAs to the damaged cardiac tissue. Together, the advances in our understanding of cardiac development, recent advances in microRNA-based therapeutics, and innovative drug delivery systems, highlight exciting opportunities for effective therapies for myocardial infarction and heart failure.
|Number of pages||17|
|Journal||World Journal of Cardiology|
|Publication status||Published - 26-Feb-2016|
- PLURIPOTENT STEM-CELLS, ACUTE MYOCARDIAL-INFARCTION, CARDIOVASCULAR DRUG-DELIVERY, CARDIOMYOCYTE-LIKE CELLS, HEART FIELD DEVELOPMENT, MUSCLE GENE-EXPRESSION, IN-VIVO, HUMAN FIBROBLASTS, PROGENITOR CELLS, MAMMALIAN HEART